Evidence map›Paper›PMID 24971615›Full record

ArticleEndocrinology2014

ROS1 signaling regulates epithelial differentiation in the epididymis.

Hyun Jung Jun, Jeremy Roy, Tegan B Smith, Levi B Wood, Keara Lane, Steve Woolfenden, Diana Punko, Roderick T Bronson, Kevin M Haigis, Sylvie Breton and 1 more

Open access · greenAbstract read
In one paragraph

Article in Endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Epithelial and mesenchymal fate decisions in Wolffian duct development.Trends in endocrinology and metabolism: TEM · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Hyun Jung JunMolecular Oncology Research Institute (H.J.J., S.W., D.P., A.C), Tufts Medical Center, Boston, Massachusetts 02111; Center for Cancer Research (K.L., A.C.), Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; Program in Membrane Biology and Division of Nephrology and Center for Systems Biology (J.R., T.B.S., S.B.) and Molecular Pathology Unit (L.B.W., K.M.H.), Massachusetts General Hospital, Boston, Massachusetts 02114; Department of Pathology (R.T.B), Harvard Medical School, Boston, Massachusetts 02115; and Department of Neurosurgery and Program in Genetics (A.C), Tufts University School of Medicine, Boston, Massachusetts 02111.
Jeremy Roy
Tegan B Smith
Levi B Wood
Keara Lane
Steve Woolfenden
Diana Punko
Roderick T Bronson
Kevin M Haigis
Sylvie Breton
Al Charest
Massachusetts General Hospital · USTufts Medical Center · USCenter for Cancer Research · USCenter for Systems Biology · USHarvard University · USMassachusetts Institute of Technology · USMolecular Oncology (United States) · US

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHAREST, ALAIN · 1996 to 2021
$30.9M
Transfer of grant 5R01HD040793 - Intercellular networks and luminal acidification in the male reproductive tractR01HD040793 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI BRETON, SYLVIE · 2001 to 2021
$6.6M
Understanding and Eliminating Oncogenic EGFR Signaling in Malignant GliomaU01CA141556 · NCI · TUFTS MEDICAL CENTER · PI CHAREST, ALAIN · 2009 to 2013
$3.3M
3-Dimensional modeling of basal cell function in pseudostratified epitheliaR01DK085715 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BRETON, SYLVIE · 2009 to 2013
$2.7M
NCI NIH HHS P01 CA069246NCI NIH HHS U01 CA141556NICHD NIH HHS R01 HD040793NIDDK NIH HHS R01 DK085715NIDDK NIH HHS R01 DK085715-05
6 · The paper itself

Abstract

The initial segment (IS) of the epididymis plays an essential role in male fertility. The IS epithelium is undifferentiated and nonfunctional at birth. Prior to puberty, the epithelium undergoes differentiation that leads to the formation of a fully functional organ. However, the mechanistic details of this program are not well understood. To explore this further, we used genetic engineering to create a kinase dead allele of the ROS1 receptor tyrosine kinase in mice and studied the effects of ROS1 tyrosine kinase activity on the differentiation of the IS epithelium. We show that the expression and activation of ROS1 coincides with the onset of differentiation and is exclusively located in the IS of the maturing and adult mouse epididymides. Here we demonstrate that the differentiation of the IS is dependent on the kinase activity of ROS1 and its downstream effector MEK1/2-ERK1/2 signaling axis. Using genetic engineering, we show that germ line ablation of ROS1 kinase activity leads to a failure of the IS epithelium to differentiate, and as a consequence sperm maturation and infertility were dramatically perturbed. Pharmacological inhibition of ROS1 kinase activity in the developing epididymis, however, only delayed differentiation transiently and did not result in infertility. Our results demonstrate that ROS1 kinase activity and the ensuing MEK1/2-ERK1/2 signaling are necessary for the postnatal development of the IS epithelium and that a sustained ablation of ROS1 kinase activity within the critical window of terminal differentiation abrogate the function of the epididymis and leads to sterility.

Indexed as

Cell DifferentiationMAP Kinase Signaling SystemAnimalsEpididymisEpithelial CellsMaleMiceProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesSpermatozoaProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRos1 protein, mouse

Identifiers

PMID24971615
PMCPMC4138574
OpenAlexW2034669655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.